BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34923990)

  • 1. LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis.
    Hu SP; Ge MX; Gao L; Jiang M; Hu KW
    Cancer Cell Int; 2021 Dec; 21(1):686. PubMed ID: 34923990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCAT6 may be a new prognostic biomarker in various cancers: a meta-analysis and bioinformatics analysis.
    Shi SB; Cheng QH; Gong SY; Lu TT; Guo SF; Song SM; Yang YP; Cui Q; Yang KH; Qian YW
    Cancer Cell Int; 2021 Jul; 21(1):370. PubMed ID: 34247605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis.
    Zhang F; Zhang G; Zhang H; Pu X; Chi F; Zhang D; Xin X; Gao M; Luo W; Li X
    Front Genet; 2022; 13():944278. PubMed ID: 36437956
    [No Abstract]   [Full Text] [Related]  

  • 5. LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis.
    Zhang H; Zhang G; Zhang F; Yang X; Li E; Wang B; Xu P; Zhang D; Guo L; Huang X
    Front Genet; 2022; 13():998442. PubMed ID: 36437914
    [No Abstract]   [Full Text] [Related]  

  • 6. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 7. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.
    Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H
    Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis.
    Wang D; Zhang H; Fang X; Zhang X; Liu H
    Cancer Cell Int; 2020; 20():109. PubMed ID: 32280301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma.
    Tu Y; Cai Q; Zhu X; Xu M
    Braz J Med Biol Res; 2021; 54(2):e9161. PubMed ID: 33439936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating
    Wei X; Gu X; Ma M; Lou C
    Onco Targets Ther; 2019; 12():6323-6335. PubMed ID: 31496735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis.
    Lin J; Li G; Bai Y; Xie Y
    Aging (Albany NY); 2023 Mar; 15(7):2503-2524. PubMed ID: 36996493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA HCP5 in cancer.
    Zou Y; Chen B
    Clin Chim Acta; 2021 Jan; 512():33-39. PubMed ID: 33245911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of LncRNA SNHG14 as a biomarker of clinicopathological and prognosis value in human cancers: A meta-analysis and bioinformatics analysis.
    Liu B; Lu T; Wang Y; Zhang G; Fu L; Yu M; Yang K; Cai H
    Front Genet; 2022; 13():945919. PubMed ID: 36276965
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Wang Y; Yu Z; Shi W; Shen J; Guan Y; Ni F
    Bioengineered; 2022 Apr; 13(4):9301-9311. PubMed ID: 35389828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis.
    Zhu H; Zhao S; Jiao R; Wang H; Tang R; Wu X; Wang F; Ge X; Li Q; Miao L
    Cancer Cell Int; 2020; 20():304. PubMed ID: 32675944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.